Sign in Subscribe
Children

Hepatocellular Carcinoma in Children and the Impact of Living-Donor Liver Transplantation on Outcome

Strategic Insights

— 1 min read

A study published in Pediatric Transplantation has revealed that hepatocellular carcinoma (HCC) predominantly occurs in older children and is often associated with liver cirrhosis. Liver transplantation has been shown to be a viable option for long-term cure in these cases. A retrospective review of 13 children with chronic liver disease and HCC was conducted to evaluate the outcome and impact of living-donor orthotopic liver transplantation (OLT) on survival. The study found that OLT significantly improved survival rates, with 1 and 4-year survival rates of 53.3% and 26.6%, respectively, compared to 33% and 16.6% in non-transplanted children.

Key Takeaways:

  • The study involved 13 children with chronic liver disease and HCC, with a mean age of 6.4 years and a median number of tumor nodules of three.
  • The underlying liver diseases were tyrosinemia type 1, chronic hepatitis B infection, and glycogen storage disease type 1.
  • Alfa-feto protein levels were elevated in all patients except one, indicating the presence of HCC.
  • The Kaplan-Meier survival curves showed a significant improvement in survival rates among transplanted children.
  • The 1 and 4-year survival rates for all patients were 53.3% and 26.6%, respectively, with transplanted children showing significantly higher survival rates (72% and 72%).
  • No patient had tumor recurrence at a median follow-up of 36 months after OLT.

Statistics:

  • Mean age of patients: 6.4 years
  • Median number of tumor nodules: three
  • Median maximal diameter of tumor nodules: 3.4 cm
  • Pediatric end-stage liver disease (PELD) score for HCC: 18-44
  • Model for end-stage liver disease (MELD) score for HCC: 1-44
  • 1-year survival rate: 53.3%
  • 4-year survival rate: 26.6%
  • Survival rate for transplanted children: 72% and 72% at 1 and 4 years, respectively
  • Survival rate for non-transplanted children: 33% and 16.6% at 1 and 4 years, respectively

Sources:

  • C. Arikan et al., "Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome" (Pediatr Transplant, 2006;10(1):42-47)
  • World Disease Weekly, "Hepatocellular carcinoma in children and the impact of living-donor liver transplantation on outcome" (2006)
  • NewsRx.com, "Hepatocellular carcinoma in children and the impact of living-donor liver transplantation on outcome" (2006)

Read more